{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:34:34Z","timestamp":1791891274231,"version":"4.3.4"},"reference-count":40,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1404.070969","type":"journal-article","created":{"date-parts":[[2009,1,26]],"date-time":"2009-01-26T21:48:52Z","timestamp":1233006532000},"page":"e1-e1","source":"Crossref","is-referenced-by-count":56,"title":["Conference Report on Public Health and Clinical Guidelines for Anthrax"],"prefix":"10.3201","volume":"14","author":[{"given":"Eric Jacob","family":"Stern","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin Broome","family":"Uhde","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean Vincent","family":"Shadomy","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Messonnier","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","published-online":{"date-parts":[[2008,4]]},"reference":[{"key":"key-10.3201\/eid1404.070969-201210301349-R1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3201\/eid0802.01-0521","article-title":"Conference Summary: Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax.","volume":"8","author":"Bell","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1404.070969-201210301349-R2","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1086\/512372","article-title":"A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor.","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1404.070969-201210301349-R3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3201\/eid0810.020353","article-title":"Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.","volume":"8","author":"Jernigan","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1404.070969-201210301349-R4","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3201\/eid0810.020349","article-title":"Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence.","volume":"8","author":"Shepard","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1404.070969-201210301349-R5","first-page":"1024","article-title":"Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices.","volume":"51","author":"CDC","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1404.070969-201210301349-R6","first-page":"1","article-title":"Responding to detection of aerosolized Bacillus anthracis by autonomous detection systems in the workplace.","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1404.070969-201210301349-R7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3109\/00365549109024319","article-title":"Antimicrobial susceptibility of Bacillus anthracis.","volume":"23","author":"Doganay","year":"1991","journal-title":"Scand J Infect Dis"},{"key":"key-10.3201\/eid1404.070969-201210301349-R8","first-page":"95","article-title":"Antimicrobial susceptibility of Bacillus anthracis.","volume":"68","author":"Lightfoot","year":"1990","journal-title":"Salisbury Med Bull"},{"key":"key-10.3201\/eid1404.070969-201210301349-R9","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1128\/JCM.42.8.3626-3634.2004","article-title":"MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest.","volume":"42","author":"Turnbull","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1404.070969-201210301349-R10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1128\/JB.185.3.823-830.2003","article-title":"\u00df-lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain.","volume":"185","author":"Chen","year":"2003","journal-title":"J Bacteriol"},{"key":"key-10.3201\/eid1404.070969-201210301349-R11","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1128\/AAC.47.6.2040-2042.2003","article-title":"Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis.","volume":"47","author":"Materon","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1404.070969-201210301349-R12","first-page":"909","article-title":"Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1404.070969-201210301349-R13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/jac\/dkh258","article-title":"Selection of Bacillus anthracis isolates resistant to antibiotics.","volume":"54","author":"Athamna","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid1404.070969-201210301349-R14","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1128\/AAC.47.7.2362-2365.2003","article-title":"In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin.","volume":"47","author":"Price","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1404.070969-201210301349-R15","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1128\/AAC.44.6.1766-1766.2000","article-title":"In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne.","volume":"44","author":"Choe","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1404.070969-201210301349-R16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0924-8579(01)00464-2","article-title":"In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones.","volume":"18","author":"Brook","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid1404.070969-201210301349-R17","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","article-title":"Postexposure prophylaxis against experimental inhalation anthrax.","volume":"167","author":"Friedlander","year":"1993","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1404.070969-201210301349-R18","first-page":"55679","article-title":"Food and Drug Administration. Prescription Drug Products: Doxycycline and penicillin G procaine administration for inhalational anthrax (post-exposure).","volume":"66","author":"Department of Health and Human Services","year":"2001","journal-title":"Fed Regist"},{"key":"key-10.3201\/eid1404.070969-201210301349-R19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.7326\/0003-4819-111-12-1041","article-title":"Anaphylactoid reactions reported after treatment wth ciprofloxacin.","volume":"111","author":"Davis","year":"1989","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid1404.070969-201210301349-R20","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1001\/archderm.1997.03890460044005","article-title":"Comparative safety of tetracycline, minocycline and doxycycline.","volume":"133","author":"Shapiro","year":"1997","journal-title":"Arch Dermatol"},{"key":"key-10.3201\/eid1404.070969-201210301349-R21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1086\/377738","article-title":"Serious adverse events among participants in the Centers for Disease Control and Prevention's anthrax vaccine and antimicrobial availability program for persons at risk for bioterrorism-related inhalational anthrax.","volume":"37","author":"Tierney","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1404.070969-201210301349-R22","unstructured":"Ortho-McNeil Pharmaceutical. Product insert, Levaquin (Levofloxacin) tablets, 2004."},{"key":"key-10.3201\/eid1404.070969-201210301349-R23","first-page":"185","article-title":"Amoxicillin in paediatrics, with special reference to its excretion into bronchial secretion.","volume":"18","author":"Weingartner","year":"1980","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"key-10.3201\/eid1404.070969-201210301349-R24","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1136\/thx.49.11.1134","article-title":"Concentration of amoxycillin and clavulanate in lung compartments in adults without pulmonary infection.","volume":"49","author":"Cook","year":"1994","journal-title":"Thorax"},{"key":"key-10.3201\/eid1404.070969-201210301349-R25","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.7973702","article-title":"The Sverdlovsk anthrax outbreak of 1979.","volume":"266","author":"Meselson","year":"1994","journal-title":"Science"},{"key":"key-10.3201\/eid1404.070969-201210301349-R26","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1073\/pnas.0602748103","article-title":"Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.","volume":"103","author":"Vietri","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid1404.070969-201210301349-R27","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1016\/j.vaccine.2006.01.054","article-title":"Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series.","volume":"24","author":"Pittman","year":"2006","journal-title":"Vaccine"},{"key":"key-10.3201\/eid1404.070969-201210301349-R28","first-page":"941","article-title":"Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1404.070969-201210301349-R29","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1086\/374843","article-title":"Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?","volume":"36","author":"Mayer","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1404.070969-201210301349-R30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00009","article-title":"Accuracy of screening for inhalational anthrax after a bioterrorist attack.","volume":"139","author":"Hupert","year":"2003","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid1404.070969-201210301349-R31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1473-3099(05)70113-4","article-title":"Management of anthrax meningitis.","volume":"5","author":"Sejvar","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid1404.070969-201210301349-R32","first-page":"691","article-title":"Pathology of experimental inhalation anthrax in the rhesus monkey.","volume":"73","author":"Fritz","year":"1995","journal-title":"Lab Invest"},{"key":"key-10.3201\/eid1404.070969-201210301349-R33","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1404.070969-201210301349-R34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-144-4-200602210-00009","article-title":"K.M. M, Owens DK. Systematic review: a century of inhalational anthrax cases from 1900 to 2005.","volume":"144","author":"Holty","year":"2006","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid1404.070969-201210301349-R35","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1073\/pnas.90.6.2291","article-title":"Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.","volume":"90","author":"Abramova","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid1404.070969-201210301349-R36","first-page":"909","article-title":"Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1404.070969-201210301349-R37","doi-asserted-by":"publisher","first-page":"632","DOI":"10.2105\/AJPH.52.4.632","article-title":"Field evaluation of a human anthrax vaccine.","volume":"52","author":"Brachman","year":"1962","journal-title":"Am J Public Health"},{"key":"key-10.3201\/eid1404.070969-201210301349-R38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/milmed\/151.2.71","article-title":"Treatment of anthrax in man: history and current concepts.","volume":"151","author":"Knudson","year":"1986","journal-title":"Mil Med"},{"key":"key-10.3201\/eid1404.070969-201210301349-R39","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0029-7844(01)01769-0","article-title":"ACOG Committee Opinion number 268, February 2002. Management of asymptomatic pregnant or lactating women exposed to anthrax. American College of Obstetricians and Gynecologists.","volume":"99","author":"Committee on Obstetric Practice","year":"2002","journal-title":"Obstet Gynecol"},{"key":"key-10.3201\/eid1404.070969-201210301349-R40","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/jama.287.12.1556","article-title":"Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among US Army women.","volume":"287","author":"Wiesen","year":"2002","journal-title":"JAMA"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/14\/4\/07-0969_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T14:27:20Z","timestamp":1732631240000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/14\/4\/07-0969_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,4]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1404.070969","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}